Label: BOOSTERVITE- multivitamin tablet
- NDC Code(s): 59088-022-54
- Packager: PureTek Corporation
- Category: HUMAN PRESCRIPTION DRUG LABEL
- DEA Schedule: None
- Marketing Status: unapproved drug other
DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Drug Label Information
Updated June 18, 2026
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
-
DESCRIPTION:
Each Tablet Contains:
Vitamin C (as ascorbic acid)……………….……………… 100 mg
Vitamin D3 (as cholecalciferol)…………….……. 10 mcg (400 IU)
Thiamin (as thiamine mononitrate)…………...……………. 10 mg
Riboflavin ...................…………………………...………….. 10 mg
Niacin (as niacinamide)…………………………....…………10 mg
Vitamin B6 (as pyridoxine hydrochloride)………….……….10 mg
Folate (as L-5-Methyltetrahydrofolate calcium salt)……….. 1700 mcg DFE
(1000 mcg L-5-Methylfolate)
Vitamin B12 (as methylcobalamin)………………….….... 100 mcg
Biotin (as d-Biotin)……………………...…….................... 300 mcg
Pantothenic Acid (as d-Calcium Pantothenate)………....… 50 mg
Iron (as Ferrous Fumarate)……………………………......... 18 mg
Withania somnifera (Ashwagandha) Root Powder….....…. 60 mg
Brassica oleracea acephala (Kale) Powder……….…...…. 2.5 mg
Brassica oleracea italica (Broccoli) Sprout Powder..…...... 2.5 mg
Citrus sinensis (Orange) Juice Powder……....................... 2.5 mg
Prunus cerasus (Tart Cherry) Extract................................. 2.5 mgOther Ingredients:
Croscarmellose Sodium, Dicalcium Phosphate, Magnesium Stearate (vegetable source), Microcrystalline Cellulose, Silicon Dioxide, Stearic Acid (vegetable source), Coating (Hydroxypropyl Methylcellulose, Polyethylene Glycol 400, Organic Maltodextrin, Organic Sunflower Lecithin, Organic Sunflower Oil, Organic Guar Gum). - INDICATIONS AND USAGE:
- CONTRAINDICATIONS:
-
WARNING:
Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.
Administration of folate alone is improper therapy for pernicious anemia and other megaloblastic anemias in which vitamin B12 is deficient. -
PRECAUTIONS:
Folate in doses above 0.1 mg daily may obscure pernicious anemia, in that hematologic remission can occur while neurological manifestations remain progressive. There is a potential danger in administering folate to patients with undiagnosed anemia, since folate may obscure the diagnosis of pernicious anemia by alleviating the hematologic manifestations of the disease while allowing the neurological complications to progress. This may result in severe nervous system damage before the correct diagnosis is made.
Adequate doses of vitamin B12 may prevent, halt, or improve the neurological changes caused by pernicious anemia. The patient’s medical conditions and consumption of other drugs, herbs, and/or supplements should be considered. Use with caution in patients receiving sedatives, antihypertensive agents, antidiabetic medications, thyroid hormone therapy, or immunosuppressive therapy, as ashwagandha may potentiate pharmacologic effects.To be used only under the supervision of a healthcare provider.
Drug Interactions:
Boostervite™ is not recommended for use in patients receiving levodopa, as pyridoxine may antagonize the effects of levodopa.
Pyridoxine may antagonize levodopa effects. It may also increase bleeding risk with anticoagulants (e.g., heparin, warfarin) or antiplatelet agents (e.g., aspirin, clopidogrel).Adverse Reactions:
Allergic sensitization and other hypersensitivity reactions have been reported with oral folate supplementation.
Ferrous Fumarate: Gastrointestinal disturbances, including anorexia, nausea, diarrhea, and constipation, have been reported. These effects are generally mild and may resolve with continued use.
Administration of Boostervite™ with food may reduce the occurrence of gastrointestinal disturbances, although iron absorption may be decreased when taken with meals. Adverse reactions have been reported with specific vitamins and minerals but generally at levels substantially higher than those contained herein. However, allergic and idiosyncratic reactions are possible at lower levels. Iron, even at the usual recommended levels, has been associated with gastrointestinal intolerance in some patients.
Call your healthcare provider for medical advice about side effects. You may report side effects to PureTek Corporation at 1-877-921-7873. You may also report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch.
-
OVERDOSE:
Signs and symptoms: Iron is toxic in excessive amounts. Acute ingestion of iron may cause nausea, vomiting, abdominal pain, and in severe cases, gastrointestinal bleeding, shock, cardiovascular collapse, and death. Other symptoms may include pallor, cyanosis, melena (black tarry stools), drowsiness, and coma. Severe reactions, including fatalities, have occurred in children from accidental overdose. The estimated toxic dose of orally ingested elemental iron is approximately 300 mg/kg body weight.
Treatment:
For management of iron overdosage, initiate appropriate supportive and symptomatic therapy.
Gastric lavage may be performed using sodium bicarbonate solution or milk. Intravenous fluids and electrolyte replacement should be administered as indicated. Oxygen therapy may be required.
In cases of severe toxicity, chelation therapy with appropriate agents (e.g., deferoxamine) should be considered. Exchange transfusion may be indicated in life-threatening situations.
Management should be guided by a healthcare provider based on clinical status and laboratory parameters. - USE IN SPECIFIC POPULATIONS:
- CLINICAL PHARMACOLOGY:
- DOSAGE AND ADMINISTRATION:
-
HOW SUPPLIED:
Boostervite™ tablets are yellow to brown, speckled, film-coated tablets, supplied in bottles of 30 tablets (NDC 59088-022-54). Dispense in a tight, light-resistant container as defined in the USP/NF, with a child-resistant closure.
Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from light and moisture.
- STORAGE AND HANDLING
- Boostervite™
-
INGREDIENTS AND APPEARANCE
BOOSTERVITE
multivitamin tabletProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:59088-022 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength FERROUS FUMARATE (UNII: R5L488RY0Q) (FERROUS CATION - UNII:GW89581OWR) FERROUS CATION 18 mg PANTOTHENIC ACID (UNII: 19F5HK2737) (PANTOTHENIC ACID - UNII:19F5HK2737) PANTOTHENIC ACID 50 mg ORANGE JUICE (UNII: 5A9KE2L9L3) (ORANGE JUICE - UNII:5A9KE2L9L3) ORANGE JUICE 2.5 mg BIOTIN (UNII: 6SO6U10H04) (BIOTIN - UNII:6SO6U10H04) BIOTIN 300 ug RIBOFLAVIN (UNII: TLM2976OFR) (RIBOFLAVIN - UNII:TLM2976OFR) RIBOFLAVIN 10 mg NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) NIACINAMIDE 10 mg ASCORBIC ACID (UNII: PQ6CK8PD0R) (ASCORBIC ACID - UNII:PQ6CK8PD0R) ASCORBIC ACID 100 mg LEVOMEFOLATE CALCIUM (UNII: A9R10K3F2F) (LEVOMEFOLIC ACID - UNII:8S95DH25XC) LEVOMEFOLIC ACID 1000 ug METHYLCOBALAMIN (UNII: BR1SN1JS2W) (METHYLCOBALAMIN - UNII:BR1SN1JS2W) METHYLCOBALAMIN 100 ug THIAMINE MONONITRATE (UNII: 8K0I04919X) (THIAMINE ION - UNII:4ABT0J945J) THIAMINE 10 mg PYRIDOXINE HYDROCHLORIDE (UNII: 68Y4CF58BV) (PYRIDOXINE - UNII:KV2JZ1BI6Z) PYRIDOXINE 10 mg CHOLECALCIFEROL (UNII: 1C6V77QF41) (CHOLECALCIFEROL - UNII:1C6V77QF41) CHOLECALCIFEROL 10 ug BROCCOLI SPROUT (UNII: 128UH9LOAE) (BROCCOLI SPROUT - UNII:128UH9LOAE) BROCCOLI SPROUT 2.5 mg PRUNUS CERASUS (BITTER CHERRY) FRUIT EXTRACT (UNII: 1L29G6428X) (PRUNUS CERASUS (BITTER CHERRY) FRUIT - UNII:1L29G6428X) PRUNUS CERASUS (BITTER CHERRY) FRUIT EXTRACT 2.5 mg KALE (UNII: 0Y3L4J38H1) (KALE - UNII:0Y3L4J38H1) KALE 2.5 mg WITHANIA SOMNIFERA ROOT (UNII: V038D626IF) (WITHANIA SOMNIFERA ROOT - UNII:V038D626IF) WITHANIA SOMNIFERA ROOT 60 mg Inactive Ingredients Ingredient Name Strength LECITHIN, SUNFLOWER (UNII: 834K0WOS5G) DICALCIUM PHOSPHATE (UNII: L11K75P92J) MAGNESIUM STEARATE (UNII: 70097M6I30) HYDROXYPROPYL METHYLCELLULOSE (UNII: 3NXW29V3WO) POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ) STEARIC ACID (UNII: 4ELV7Z65AP) MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) CROSCARMELLOSE SODIUM (UNII: M28OL1HH48) GUAR GUM (UNII: E89I1637KE) SUNFLOWER OIL (UNII: 3W1JG795YI) MALTODEXTRIN (UNII: 7CVR7L4A2D) Product Characteristics Color yellow (yellow to brown, speckled, film-coated tablets) Score no score Shape CAPSULE (Caplet) Size 19mm Flavor Imprint Code Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:59088-022-54 30 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product 06/19/2026 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 06/19/2026 Labeler - PureTek Corporation (785961046) Establishment Name Address ID/FEI Business Operations PureTek Corporation 785961046 manufacture(59088-022) , analysis(59088-022) , pack(59088-022) , label(59088-022)
